CCX (ASX) Discounting ; product strategy shift

Originally posted by natnicnak: ↑

CCX exposed a major weakness in its business model in the second half of calendar 2022; a product range that lacks sufficient differentiation from what is commonly available.

This weakness forced it into a severe bout of discounting to meet the activities of its peer group.

80% was common across the Collective, triggering huge falls in gross margins and, for what was inconceivable at 30 June 2022, a loss result for the first half 2023.

The best thing Phil Ryan and his team could do over coming days is to take a group tour to a store like their local Lululemon to review and learn what true brand and product line differentiation looks like and the power in pricing that it delivers to its owners.

The Board’s AGM special incentives for stock reduction didn’t go far enough; the executive team should be mandated and incentivised to progressively grow non-(heavily) discounted product sale categories. By way of example, 40% of product categories to be sold no lower than 20% of list price in year 1, 50% in year 2 and so forth.

This will force the executive team to move away from a discount shop culture, more Peter Alexander and Lululemon rather than Katies and the rest of the Mosaic brands stable that the management team knows only too well.

I believe the executive team has invested heavily both by way of time and cost in the online and distribution capability of the business in recent years, unfortunately at the expense of limited product differentiation. Whilst distribution capability has a long way to go - Evans is not directly sold outside of the UK, Avenue not outside of the USA (sadly and embarrassingly), design and non-discounted product has suffered as a result.

’She’ will buy the uniquely branded product of desire ahead of a discounted line that ‘she’ can buy on multitude of competitor websites.

Another way of looking at this is that a focus on margin rather than gross sales reveals the following; higher gross sales (sheer volume) benefit third party manufacturers in second and third world countries, including the executive team that justifies its effort by way of a larger business managed whereas better margins and head office cost control equate to higher multiples on earnings benefitting shareholders, the stakeholders funding the Board and executive team’s remuneration.

Once that switch is enforced, step 2 for the Board is to task the executive team with a total global sales target: $1 billion in 4 years.

I doubt the Board has the depth of talent and muscle to sufficiently act and think independently of management to do this, which is why Board renewal is a pressing issue at CCX.

One needs to look no further than the catastrophe that we have endured over the last few months.

Expand

ccx management purchasing stock ahead of supply chain impacts is a good idea imo. they noted 50% are for future season collections in last annual report and so i dont believe we are in a position where we will have rubbish stock.. even with no ebitda we will convert our inventory back to cash so no probs.

No.	Vol.	Price($)
26	2234438	12.5¢

No.

Vol.

Price($)

2234438

12.5¢

Price($)	Vol.	No.
13.0¢	24000	1

Price($)

Vol.

No.

13.0¢

24000

No.	Vol.	Price($)
26	2234438	0.125
37	1886683	0.120
19	602856	0.115
16	364028	0.110
17	274472	0.105

No.

Vol.

Price($)

2234438

0.125

1886683

0.120

602856

0.115

364028

0.110

274472

0.105

Price($)	Vol.	No.
0.130	24000	1
0.135	345055	13
0.140	132522	6
0.145	381982	4
0.150	633462	8

Price($)

Vol.

No.

0.130

24000

0.135

345055

0.140

132522

0.145

381982

0.150

633462

(20min delay)
Last 12.5¢		Change -0.005(3.85%)		Mkt cap ! $28.99M

Open	High	Low	Value	Volume
13.0¢	13.5¢	12.5¢	$690.7K	5.333M

ccx management purchasing stock ahead of supply chain impacts is...

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

ccx management purchasing stock ahead of supply chain impacts is...

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News